-
Most Recent
Search Results
240 results for bmti
Industry Group Rank Limit Bristol-Myers Squibb Co (BMY) Rating
The current recommendation of Hold for Bristol-Myers Squibb Co (NYSE:BMY) has been derived by using Louis Navellier’s methodology for investing and his Portfolio Grader stock…
At $65.63, Bristol-Myers Squibb Co (BMY) a Buy
At $65.63, Bristol-Myers Squibb Co (BMY) a Buy based on the latest stock market ratings, and comparative pricing of its shares.
Strong Quant Score Make Bristol-Myers Squibb Co (BMY) a Buy at recent price of $60.96
The a Buy rating for BMY is based on the Portfolio Grader stock evaluator. The methodology for investing incorporated in this analytical tool researches and…
Bristol-Myers Squibb Co (BMY) Sees Downgrade….. Poor Earnings Momentum
Currently, Bristol-Myers Squibb Co (NYSE:BMY) has a Hold using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current overall…
Rating for Bristol-Myers Squibb Co (BMY) Drops….. Wilting Earnings Visibility
The current recommendation of Hold for Bristol-Myers Squibb Co (NYSE:BMY) is the result of using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates…
Shares in Bristol-Myers Squibb Co (BMY) and Merck & Co., Inc. (MRK) Need to Chill
Friday’s action in pharma giants Merck (MRK) and Bristol-Myers Squibb (BMY) is likely overdone to the upside and down.
Bristol-Myers Squibb Co (BMY) Stock Raised to Hold
Portfolio Grader currently ranks Bristol-Myers Squibb Co (NYSE:BMY) a Hold. With exclusive fundamental and quantitative analytical tools developed by Louis Navellier, this analytical tool evaluates…
Go Long Bristol-Myers Squibb Co (BMY) Stock for Panic Profits!
Pharmaceutical stocks like Bristol-Myers Squibb (BMY) have been toxic for months, but BMY stock is about to turn lemons into lemonade.
3 Medical Devices Stocks to Sell Now
The ratings of three Medical Devices stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…
BMY Stock: Don’t Try to Catch This Falling Knife … Yet
Bristol-Myers (BMY) stock is a hot mess right now, but it still has long-term value in its cancer drug pipeline.
BMY Stock: It’s Time to Buy Bristol-Myers Squibb Co
Following a failed cancer drug approval, BMY stock dropped nearly 16%. That appears to be an overreaction, so time to take a bullish stance.
Why Is Avidity Biosciences (RNA) Stock Up 15% Today?
RNA stock is jumping over 15% in early trading after Avidity announced its expanded alliance with Bristol-Myers Squibb.
Bristol-Myers Squibb Co (BMY) Suffers Heavy Dose of Disappointment
BMY stock — at around $49 — is now fairly valued. But given its failure rate, waiting for Bristol-Myers to get to “cheap” is the…
Best Stocks 2022: Why Bristol-Myers Squibb (BMY) Stock Is a Clear Winner
There’s a reason BMY stock is currently winning our Best Stocks for 2022 contest. Investors should buy BMY for value, safety and dividends.
Bristol-Myers Squibb Has Great Potential Ahead of Earnings
Ahead earnings, Bristol-Myers Squibb is a great value play. In fact, BMY stock is worth 30%-70% more than its current share price.
BITI ETF Gains as Investors Look to Short Bitcoin Amid Crypto Crash
The ProShares Short Bitcoin Strategy ETF, or BITI, has gotten off to a strong start as investors bet against the biggest cryptocurrency.
Bristol-Myers Squibb Co: The BMY Freefall Is Overdone
BMY stock has sustained a technical beatdown over the past couple of days. But Bristol-Myers Squibb is arriving at promising support.
Why EOG Resources Inc (EOG), Merck & Co., Inc. (MRK) and Rackspace Hosting, Inc. (RAX) Are 3 of Today’s Best Stocks
As stocks jumped following the jobs report, EOG, MRK and RAX were among Friday’s standouts.
Trade of the Day: BMY Stock Triggers New Buy Signal
Bristol-Myers Squibb Co appears to be headed to new highs.sa
Bristol-Myers Becomes a Cancer-Fighting Giant With Celgene Buyout
With its Celgene (CELG) buyout, Bristol-Meyers is getting a heck of a deal and will make BMY stock the top-dog cancer medicines.
Buy Bristol-Myers Squibb Co (BMY) Stock Without Fear
The consensus is that Trump will destroy the Biotech industry. I bet this will pass with little change, so go long BMY with room for…
Bristol-Myers Squibb Is a Dirt-Cheap Buy Before Earnings
Thanks to its Celgene acquisition, Bristol-Myers Squibb looks attractive ahead of earnings. Here’s why you should buy BMY stock.
2 – 10 of 240 results
